China SXT Pharmaceuticals Inc (SXTC) gains 4.70% for July 21

Equities Staff  |

China SXT Pharmaceuticals Inc (NASDAQ: SXTC) shares gained 4.70%, or $0.07 per share, to close Wednesday at $1.56. After opening the day at $1.43, shares of China SXT fluctuated between $1.56 and $1.42. 966,312 shares traded hands a decrease from their 30 day average of 6,748,347. Wednesday's activity brought China SXT’s market cap to $24,202,458.

China SXT is headquartered in Po Box 905, Road Town..

About China SXT Pharmaceuticals Inc

Founded in 2005 and headquartered in Taizhou City, Jiangsu Province, China, China SXT Pharmaceuticals, Inc. is an innovative pharmaceutical company focusing on the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces, which is a type of Traditional Chinese Medicine that has been processed to be ready for use.

Visit China SXT Pharmaceuticals Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on China SXT Pharmaceuticals Inc and to follow the company’s latest updates, you can visit the company’s profile page here: China SXT Pharmaceuticals Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content